HYPHEN BioMed
FR-MF-000002214 · France · Neuville-sur-Oise
HYPHEN BioMed is registered in the European database on medical devices as a manufacturer, with 65 devices declared. It has a similarly named entry in the FDA register that we have not verified.
What this manufacturer declares
| other | 65 |
|---|
Most frequent device types declared: LMWH Control, Factor Xa (FXa) inhibitors, Antithrombin (AT) activity - AntiXa, UFH Control, Control Plasma.
No authorised representative is recorded for these devices. For a manufacturer established outside the Union that would be unusual; for one established inside it, it is normal.
United States market access
| FDA establishment register | Similar name found — unverified |
|---|---|
| Matched entry | HYPHEN BIOMED SASU (FR) · FDA 3004434070 |
| Devices in EUDAMED | 65 |
| Country of registration | France |
⚠️ A similar name exists in the FDA register. We do not assert that it is the same company — the two registers share no common identifier, and a name alone is not proof. This entry needs a human check.
Notified body certificates
| Certificate | Status | Expiry |
|---|---|---|
HX 1348148-1 | amended | 2027-12-14 |